Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II
Clinical trial NCT03020004 · COMPLETED
Trial details
- NCT number
- NCT03020004
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-11-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.